{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:07:38Z","timestamp":1778832458306,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM2020"],"award-info":[{"award-number":["SZSM2020"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jiph.2020.08.008","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T18:09:08Z","timestamp":1599674948000},"page":"1780-1786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the performance of three different cervical cancer screening modalities in a large prospective population-based cohort"],"prefix":"10.1016","volume":"13","author":[{"given":"Fangbin","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjian","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jiph.2020.08.008_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jiph.2020.08.008_bib0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jiph.2020.08.008_bib0015","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/ijc.30392","article-title":"Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries","volume":"139","author":"Simms","year":"2016","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jiph.2020.08.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx225","article-title":"Relative performance of HPV and cytology components of cotesting in cervical screening","volume":"110","author":"Schiffman","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.jiph.2020.08.008_bib0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/cncy.22192","article-title":"Age\u2010specific 3\u2010year cumulative risk of cervical cancer and high\u2010grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting","volume":"127","author":"Ge","year":"2019","journal-title":"Cancer Cytopathol"},{"issue":"9","key":"10.1016\/j.jiph.2020.08.008_bib0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.jiph.2020.08.008_bib0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jiph.2020.08.008_bib0040","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jiph.2020.08.008_bib0045","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jiph.2020.08.008_bib0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2016.04.027","article-title":"Comparison of cytology, HPV DNA testing and HPV 16\/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening","volume":"142","author":"Chatzistamatiou","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.jiph.2020.08.008_bib0055","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/ijc.32861","article-title":"Primary HPV testing with cytology versus cytology alone in cervical screening\u2014a prospective randomized controlled trial (RCT) with two rounds of screening in a Chinese population","volume":"147","author":"Chan","year":"2020","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.jiph.2020.08.008_bib0060","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-14-1353","article-title":"The role of human papillomavirus genotyping in cervical cancer screening: a large-scale evaluation of the cobas HPV test","volume":"24","author":"Schiffman","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jiph.2020.08.008_bib0065","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jcv.2015.11.021","article-title":"Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting","volume":"76 Suppl 1","author":"Poljak","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jiph.2020.08.008_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2019.12.013","article-title":"Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review","volume":"127","author":"Jansen","year":"2020","journal-title":"Eur J Cancer"},{"issue":"9916","key":"10.1016\/j.jiph.2020.08.008_bib0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jiph.2020.08.008_bib0080","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ejca.2011.03.006","article-title":"Cost-effectiveness of primary HPV screening for cervical cancer in Germany\u2014a decision analysis","volume":"47","author":"Sroczynski","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jiph.2020.08.008_bib0085","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76 Suppl 1","author":"Wentzensen","year":"2016","journal-title":"J Clin Virol"},{"issue":"11","key":"10.1016\/j.jiph.2020.08.008_bib0090","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.30375","article-title":"A cohort study of cervical screening using partial HPV typing and cytology triage","volume":"139","author":"Schiffman","year":"2016","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.jiph.2020.08.008_bib0095","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.31261","article-title":"Eurogin roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programs","volume":"143","author":"Cuschieri","year":"2018","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.jiph.2020.08.008_bib0100","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jiph.2020.08.008_bib0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.jiph.2020.08.008_bib0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jiph.2020.08.008_bib0115","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/cam4.1060","article-title":"A cross-sectional study on HPV testing with type 16\/18 genotyping for cervical cancer screening in 11,064 Chinese women","volume":"6","author":"Wu","year":"2017","journal-title":"Cancer Med"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120306298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120306298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:13:14Z","timestamp":1778829194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034120306298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1876034120306298"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2020.08.008","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the performance of three different cervical cancer screening modalities in a large prospective population-based cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2020.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}